Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) announced today a new research grant awarded to Daniela C. Zarnescu, Ph.D., Professor of Cellular and Molecular Physiology at Penn State University College of Medicine, in collaboration with Jon Njardarson, Ph.D., Professor at the University of Arizona.
Critical Path Institute Aug 8 2024 Critical Path Institute's Translational Therapeutics Accelerator announced today a new research grant awarded to Daniela C. Zarnescu, Ph.D., Professor of Cellular and Molecular Physiology at Penn State University College of Medicine , in collaboration with Jon Njardarson, Ph.D., Professor at the University of Arizona.
Dr. Zarnescu aims to identify and develop new small molecules that have the potential to protect nerve cells from degeneration. In response to receiving the grant, she expressed her enthusiasm, "I am honored to receive this grant from TRxA, alongside my collaborator Dr. Jon Njardarson. Together, we will explore new avenues in neuroprotective therapies for ALS and related diseases.
The grant is consistent with C-Path's broader commitment to foster collaboration among scientists and stakeholders by expediting the development of safe and effective therapies in neurodegenerative diseases. This is complimentary to C-Path's Critical Path for Rare Neurodegenerative Diseases Consortium which is focused on increasing the field's understanding of disease pathogenesis and natural history by quantifying disease progression.
Brain Medicine Nerve Nervous System Neurodegenerative Diseases Ph Physiology Research Sclerosis Small Molecules Therapeutics
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Scientists sets out seven steps to achieve clean indoor air post-pandemicSeven lessons learned from the COVID-19 pandemic about ventilation's crucial role in preventing the spread of airborne pathogens have been set out by world-leading air quality scientist Professor Lidia Morawska, Professor Yuguo Li from The University of Hong Kong and Professor Tunga Salthammer from the University of Surrey, UK.
Read more »
Does the onset of daylight saving time trigger unhealthy consumer behaviors?Researchers from North Carolina State University, University of Manitoba, Bern University of Applied Sciences, University of South Carolina, and California Baptist University published a new Journal of Marketing study that explores whether the onset of daylight saving time leads consumers to engage in unhealthy behaviors.
Read more »
Confirmed link between maternal asthma and child allergiesFor the first time, researchers from the University of Adelaide's Robinson Research Institute, University of South Australia and University of Queensland have confirmed maternal asthma increases risks of child allergies.
Read more »
Marshall University receives $3.3 million grant to examine genetic mechanisms behind fentanyl addictionMarshall University was awarded a $3.3 million grant (R01DA057931) from the National Institute on Drug Abuse (NIDA) to examine the genetic mechanisms that underlie fentanyl addiction.
Read more »
Tulane University leads effort in sex-based precision medicine with NIH grantIf a man and a woman each suffer a heart attack, you may assume the symptoms and diagnoses should be the same.
Read more »
Navigating the future of drug development at the C-Path Global Impact ConferenceCritical Path Institute (C-Path), whose mission is to lead collaborations that accelerate drug development, advancing better treatments for people worldwide, is proud to announce its inaugural C-Path Global Impact Conference (CGIC), taking place from September 9-11, 2024, at the Washington Marriott at Metro Center.
Read more »